THE RELATIONSHIP OF P53 PROTEIN AND LYMPH-NODE METASTASES IN INVASIVE BREAST-CANCER

被引：8

作者：

NOGUCHI, M

KITAGAWA, H

KINOSHITA, K

THOMAS, M

MIYAZAKI, I

SAITO, Y

MIZUKAMI, Y

NONOMURA, A

MICHIGISHI, T

NAKAMURA, S

机构：

[1] The Operation Center, Kanazawa University Hospital, School of Medicine, Kanazawa, 920, Takara-machi

[2] Department of Surgery II, Kanazawa University Hospital, School of Medicine, Kanazawa, 920, Takara-machi

[3] Department of Surger, Kanazawa University Hospital, School of Medicine, Kanazawa, 920, Takara-machi

[4] Department of Pathology, Kanazawa University Hospital, School of Medicine, Kanazawa, 920, Takara-machi

[5] Department of Nuclear Medicine, Kanazawa University Hospital, School of Medicine, Kanazawa, 920, Takara-machi

[6] Deparment of Medicine III, Kanazawa University Hospital, School of Medicine, Kanazawa, 920, Takara-machi

来源：

SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1994年 / 24卷 / 06期

关键词：

P53; PROTEIN; BREAST CANCER; LYMPH NODE METASTASIS;

D O I：

10.1007/BF01884570

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The p53 expression in invasive breast cancers from 106 patients was correlated with clinicopathological variables to ascertain its usefulness for estimating prognosis. The p53 expression was significantly associated with the number of axillary lymph node metastases and the presence of internal mammary lymph node metastases; however, it was not associated with age, menopausal status, histologic type, or tumor size. Although p53 expression was a significant prognostic factor according to univariate analysis, it did not appear to be an independent prognostic factor according to multivariate analysis. Thus, the prognostic power of p53 expression is likely to be weak and therefore probably of limited clinical value. Nevertheless, the number of patients in our study was small, and we believe that an investigation of a larger series of patients is indicated.

引用

页码：512 / 517

页数：6

共 32 条

[1]

Adair F., Berg J., Joubert L., Robbins G.F., Long-term follow-up of breast cancer patients: The 30-year report, Cancer, 33, pp. 1145-1150, (1974)

[2]

Fisher B., Bauer M., Wickerham L., Redmond C.K., Fisher E.R., Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, 52, pp. 1551-1557, (1983)

[3]

Lane D.P., Crawford L.V., T antigen is bound to a host protein in SV40-transformed cells, Nature, 278, pp. 261-263, (1979)

[4]

Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein B., Mutations in the p53 gene occur in diverse human types, Nature, 342, pp. 705-708, (1989)

[5]

Bartek J., Iggo R., Gannon J., Lane D.P., Genetic and immunochemical analysis of mutant p53 in breast cancer cell line, Oncogene, 5, pp. 893-899, (1990)

[6]

Davidoff A.M., Humphrey P.A., Iglehart J.D., Marks J.R., Genetic basis for p53 overexpression in human breast cancer, Proc Natl Acad Sci USA, 88, pp. 5006-5010, (1991)

[7]

Martinez J., Georgoff I., Martinez J., Levine A.J., Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein, Genes Dev, 5, pp. 151-159, (1991)

[8]

Davidoff A.M., Kerns B-JM, Iglehart J.D., Marks J.R., Maintenance of p53 alterations throughout breast cancer progression, Cancer Res, 51, pp. 2605-2610, (1991)

[9]

Thor A.D., Moore D.H., Edgerton S.M., Kawasaki E.S., Reihsaus E., Lynch H.T., Marcus J.N., Schwartz L., Chen L.C., Mayall B.H., Smith H.S., Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers, J Natl Cancer Inst, 84, pp. 845-855, (1992)

[10]

Ostrowski J.L., Sawan A., Henry L., Wright C., Henry J.A., Hennessy C., Lennard T.J.W., Angus B., Horne C.H.W., p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study, J Pathol, 164, pp. 75-81, (1991)

← 1 2 3 4 →